Summary:
Clinical research study of an investigational medication for the treatment of liver fibrosis in adults with Nonalcoholic Steatohepatitis (NASH).
Qualified Participants Must:
Be between 18 and 75 years of age
Diagnosed with NASH or fatty liver disease
Qualified Participants May Receive:
• All study medication and procedures at no cost
• Compensation for time and travel